Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 7.54 is 50% above its 5-year average of 5.02, around the middle of its 5-year range (1.60–11.72).
As of the fiscal period ended Tuesday, June 30, 2026. 14.73% below its 12-month average of 8.84.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.54.
QUICK RATIO (ACID-TEST)
7.54
QUICK RATIO (ACID-TEST) AVG TTM
8.84
QUICK RATIO (ACID-TEST) AVG 3Y
6.48
QUICK RATIO (ACID-TEST) AVG 5Y
5.02
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-14.73%
CURRENT VS 3Y AVG
+16.33%
CURRENT VS 5Y AVG
+50.17%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+124.95%
vs the sector median at left
Market Cap
$1.02B
Quick Ratio (Acid-Test)
16.35
TTM Avg
49.13
3Y Avg
36.31
5Y Avg
29.96
Market Cap
$1.02B
Quick Ratio (Acid-Test)
5.85
TTM Avg
6.12
3Y Avg
6.56
5Y Avg
10.14
Market Cap
$1.03B
Quick Ratio (Acid-Test)
1.98
TTM Avg
1.08
3Y Avg
1.74
5Y Avg
1.96
Market Cap
$1.02B
Quick Ratio (Acid-Test)
1.44
TTM Avg
1.13
3Y Avg
1.10
5Y Avg
1.10
Market Cap
$1.01B
Quick Ratio (Acid-Test)
8.42
TTM Avg
11.89
3Y Avg
15.48
5Y Avg
17.00
Market Cap
$1.05B
Quick Ratio (Acid-Test)
0.81
TTM Avg
2.16
3Y Avg
2.71
5Y Avg
2.89
Market Cap
$999.00M
Quick Ratio (Acid-Test)
19.15
TTM Avg
11.70
3Y Avg
12.62
5Y Avg
12.74
Market Cap
$987.63M
Quick Ratio (Acid-Test)
3.76
TTM Avg
1.39
3Y Avg
1.76
5Y Avg
2.46
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immatics N.V. (IMTX) | $1.02B | 7.54 | 8.84 | 6.48 | 5.02 |
| Janux Therapeutics, Inc. (JANX)vs › | $1.02B | 16.35 | 49.13 | 36.31 | 29.96 |
| Castle Biosciences, Inc. (CSTL)vs › | $1.02B | 5.85 | 6.12 | 6.56 | 10.14 |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.03B | 1.98 | 1.08 | 1.74 | 1.96 |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | 1.44 | 1.13 | 1.10 | 1.10 |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.01B | 8.42 | 11.89 | 15.48 | 17.00 |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | 0.81 | 2.16 | 2.71 | 2.89 |
| Vor Biopharma Inc. (VOR)vs › | $999.00M | 19.15 | 11.70 | 12.62 | 12.74 |
| MeiraGTx Holdings plc (MGTX)vs › | $987.63M | 3.76 | 1.39 | 1.76 | 2.46 |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $997.02M | N/A | N/A | N/A | N/A |
Quick Ratio
7.54
Excludes inventory
Current Ratio
7.54
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 7.54 |
| 2026-03-31 | 8.78 |
| 2025-12-31 | 11.72 |
| 2025-09-30 | 7.36 |
| 2025-06-30 | 8.80 |
| 2025-03-31 | 10.28 |
| 2024-12-31 | 9.26 |
| 2024-09-30 | 3.98 |
| 2024-06-30 | 3.74 |
| 2024-03-31 | 3.95 |
| 2023-12-31 | 2.87 |
| 2023-09-30 | 3.09 |
| 2023-06-30 | 2.86 |
| 2023-03-31 | 3.33 |
| 2022-12-31 | 3.54 |
| 2022-09-30 | 2.52 |
| 2022-06-30 | 2.95 |
| 2022-03-31 | 2.83 |
| 2021-12-31 | 1.60 |
| 2021-09-30 | 1.68 |
| 2021-06-30 | 2.71 |
| 2021-03-31 | 3.26 |
| 2020-12-31 | 3.08 |
| 2020-09-30 | 3.50 |
| 2020-06-30 | 1.05 |
| 2020-03-31 | 1.42 |
| 2019-12-31 | 1.77 |
| 2019-09-30 | 1.79 |
| 2019-06-30 | 1.79 |
| 2019-03-31 | 3.10 |
| 2018-12-31 | 0.00 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
